FindTrial
Sign In

Analysis of Clinicopathological Characteristics and Expression of Relevant Therapeutic Targets in Epstein-Barr Virus-Associated Gastric Cancer

Analysis of Clinicopathological Characteristics and Expression of Relevant Therapeutic Targets in Epstein-Barr Virus-Associated Gastric Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127249
Enrollment
Unknown
Registered
2026-06-28
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epstein-Barr virus (EBV)-associated gastric cancer

Interventions

EBV?associated gastric cancer group (EBVaGC group):None
EBV?negative gastric cancer group (EBVnGC group):None

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Primary gastric cancer confirmed by postoperative pathology; 2.Complete clinicopathological data available.

Exclusion criteria

Exclusion criteria: 1.History of preoperative neoadjuvant radiotherapy, chemotherapy, targeted therapy or immunotherapy; 2.Gastric stump cancer or recurrent gastric cancer; 3.Presence of other primary malignant tumors.

Design outcomes

Primary

MeasureTime frame
clinicopathological features;Expression of therapeutic targets.;—

Countries

China

Contacts

Public ContactCao Kai

The Affiliated Hospital of Xuzhou Medical University

ck004512@163.com+86 516 85805681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026